Objetivo
Our groups work on the characterization of human tumour-specific antigens recognized by T lymphocytes, the use of these antigens for therapeutic vaccination of cancer patients, and the biology of new cytokines.
Ámbito científico
Convocatoria de propuestas
Data not availableRégimen de financiación
BUR - Bursaries, grants, fellowshipsCoordinador
1200 BRUXELLES
Bélgica